OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← Harrison's Fund Ltd

2023-12-31-accounts

Company Registered number: 07782637 (England and Wales) Charity number: 1146662

HARRISON’S FUND LIMITED

REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

CONTENTS

Page
Company information 1
Report of the Trustees 2-8
Independent Examiner’s Report to the Trustees 9
Statement of financial activities 10
Balance sheet 11
Accounting policies 12-13
Notes to the financial statements 14-18

COMPANY INFORMATION

Directors/Trustees Mr A D J Smith – Chairman & CEO Mr A D J Smith – Chairman & CEO
Mrs D L Smith
Mr N Taussig
Mr J F Leabeater
Company number 07782637
Charity number 1146662
Registered office c/o Saffery LLP Principal Address: PO Box 118
Midland House Esher
2 Poole Road KT10 1FL
Bournemouth
BH2 5QY
Website www.harrisonsfund.org
Bankers The Co-operative Bank plc
Metro Bank plc
P O Box 250 One Southampton Row
Skelmersdale London
WN8 6WT WC1B 5HA
Independent Examiners Saffery LLP
Midland House
2 Poole Road
Bournemouth
BH2 5QY
Scientific Advisory Panel Prof. Steve Wilton (Head, Molecular Genetic Therapy at Uni. of W Australia)
Prof. Susan Fletcher (Principal Research Fellow at Uni. of W Australia)
Dr. Justin Roberts (Dept. of Sport and Life Sciences, Uni. of Hertfordshire)
Dr. Keith Foster

Page 1

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

The Trustees have pleasure in presenting the Annual Report and Accounts for the year ended 31 December 2023.

1. Structure, Governance and Management

The Company is a registered charity, number 1146662, and was formed as a company limited by guarantee, number 07782637, on 21 September 2011. The Charity was founded by Alex and Donna Smith in response to the diagnosis in January 2011 of their elder son, Harrison, as suffering from Duchenne Muscular Dystrophy.

The body responsible for the management of the Charity is the Board of Trustees (also Directors for the purposes of company law) of Harrison’s Fund Limited. The Board meets a minimum of four times per annum. The trustees at 31 December 2023 are set out below:

Mr A D J Smith (Chairman & CEO) Parent of Duchenne child Mrs D L Smith Parent of Duchenne child Mr J F Leabeater Mr N Taussig Parent of Duchenne Child – Director Salon Films

The only sub-committee created thus far has been the Scientific Advisory Panel to help assist the Trustees in assessing the viability of research proposals. Details of the members of this committee are shown on page 1.

New trustees are appointed by the existing Board of Trustees.

Trustees give of their time freely and no trustee remuneration was paid in the year, other than to Mr A D J Smith who became a full time employee of the company on 1 May 2013. Details of trustee expenses and related party transactions are disclosed in note 12 to the accounts. Trustees are required to disclose all relevant interests and to withdraw from decisions where a conflict of interest arises. During 2022, the charity and one of the trustees were granted shares in Sutura Therapeutics Ltd, a UK company developing novel, patent-protected gene medicines for multiple disease areas including Duchenne Muscular Dystrophy, Further information can be found in Note 7.

Page 2

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

2. Chairman’s statement

Despite the efforts of our trustees and, in particular, our staff, against the continuing unfavourable economic background we have incurred a small deficit in 2023, which we aim to reverse in the coming year, and we continue to make great efforts to reduce all non-essential expenditures to a minimum without impacting on our ability to secure our goals.

Participation in events has been falling as has the sponsorship income of those running or cycling on our behalf, so we have been active in searching out new sources of income to allow us to achieve our goals

As forecast last year, we have shifted our charitable focus to concentrate on the delivery of a mental health provision for children diagnosed with Duchenne and for their families and carers. We have recognized the importance of where we can do the most good for families in the short term and make the best use of our lower levels of income. We are not turning our backs on the funding of new research projects and these remain as part of our DNA, but we need to make the best use of our resources to help Duchenne families today.

For those of you that have visited our website, or followed our social media channels, you will have seen that the entire branding and message from these channels has been updated in line with presenting our new grant making strategy. This development work has been carried out entirely inhouse, and we have chosen to expense these costs in the 2023 figures rather than capitalise them on the balance sheet. Whilst this inevitably contributed to our deficit for the year, the trustees believe this to be the most prudent approach.

One of the strengths of a community-based charity such as Harrison’s Fund is that its community of trustees, employees, volunteers and supporters pull together to ensure that the work of the charity can continue into the future. Our community has done an amazing job in ensuring that Harrison’s Fund will continue to thrive whatever the future holds and for this I give you all my heartfelt thanks.

Page 3

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

3. What is Duchenne?

Duchenne Muscular Dystrophy is the most common fatal genetic disorder to affect children around the world. If you've got it, you can't produce dystrophin, a protein you need to build up your muscles. As a result, every muscle in the body deteriorates. At the moment there is no cure.

The facts about Duchenne are inescapable:

One in 3,500 boys is born with it, and in the UK 2,500 children have it at the moment. You can have it, no matter where you are or what your ethnic background is. A third of all cases start in the womb, with no warning before the baby is born. Girls can also get Duchenne with around 1% of Duchenne births being female.

4. Objectives, Activities and Public Benefit

The object of the Charity is to fund research being undertaken both in the UK and overseas into finding a cure for Duchenne Muscular Dystrophy. We invest in research that takes the science out from the lab, and into human clinical trials. The Trustees confirm that they have referred to the guidance contained in the Charity Commissioner’s general guidance on public benefit when reviewing the Charity’s aims and objectives and in planning future activities and setting the grant making policy.

In addition, the charity has launched “Project Chrysalis” to help bridge the gap between needing mental health support due to the devastating diagnosis and accessing the NHS services that the patient and their family needs.

Mental health therapy can be immensely beneficial for families facing a Duchenne muscular dystrophy (DMD) diagnosis. Coping with such a diagnosis can be emotionally overwhelming, and therapy offers a safe space for family members to express their feelings, fears, and concerns. Through counselling and support, therapy can help families develop coping strategies, strengthen communication, and foster resilience during the challenging journey ahead. Moreover, it provides a platform to educate family members about DMD, its progression, and available resources, enabling them to make informed decisions for their loved one's care.

Overall, mental health therapy empowers families to navigate the complexities of DMD with a greater sense of understanding, unity, and emotional well-being.

Page 4

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

5. Grant Making Policy

The Charity has established its grant making policy to achieve its objects for the public benefit to find a cure for Duchenne Muscular Dystrophy and to slow down the rate of progress of Duchenne by maintaining a sufferer’s muscular strength for longer. In addition, we have launched a brand new mental health provision for families affected by Duchenne – “Project Chrysalis”

Our Scientific Advisory Panel will advise the Board of Trustees as to which of the proposals received is the most promising in support of our stated aims and objectives.

During the year, “Project Chrysalis” grants amounting to £3,520 were made (2022 - £0).

In order to quantify the demand for mental health provision, HF conducted research into the wellbeing of children living with Duchenne and their families via and were staggered by the responses. The feedback was overwhelmingly negative regarding the provision in place through the NHS with many families feeling let down by the lack of mental health support.

We spoke to several hospitals and NHS Trusts to establish the offering to families upon receiving a Duchenne diagnosis as well to those living with the long-term effects of having a life-limiting condition. We found that there was inconsistency in the type of support offered. Some hospitals have in-house psychologists that they can refer families to, some leave it to the families’ GPs, some refer to external agencies and charities and some had neuromuscular specialist psychologists within their team. In all cases the hospitals were massively time poor, had extensive waiting lists and were in favour of a third party, such as HF, being able to offer well-being support to both children with Duchenne, and their immediate families.

A small pilot study conducted in the Duchenne community revealed remarkably positive outcomes from participation in six sessions with a clinical psychologist. Participants reported improved emotional well-being, increased coping skills, and a sense of support and understanding. The therapy sessions provided a safe space for individuals to express their emotions and concerns, leading to enhanced self-awareness and empowerment. Many also reported reduced anxiety and depression levels, and improved social connections.

The study's results highlight the significance of accessible mental health support tailored to the specific needs of the Duchenne community.

We understand the efforts made by our colleagues in the Duchenne Community to improve the Psychosocial standards of care and NHS provision for mental health support for Duchenne patients and parents, and we fully support their goal. However, we firmly believe that immediate help is crucial during times of crisis. That's why Harrison's Fund is committed to providing 'Chrysalis Grants' of up to £1000, which will enable individuals to access private therapy sessions while also assisting them in gaining access to the NHS Psychology Service waiting lists for additional and ongoing support. Our pilot study feedback indicated that the priority for funding should be with newly diagnosed parents and those facing bereavement and end of life. Chrysalis will start there and will expand as funding and scope allow and our provision grows. We will move as fast as we can. This is just the start of our aim to bridge the gap between 'Need' and NHS'S capacity.

Page 5

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

6. Management of Risk

The Trustees have in place a risk management process to assess risk and implement risk management strategies. The process identifies risks that the Charity faces, assesses the level of that risk and identifies the means of managing those risks in an effective way, and is an embedded part of organising Charity fundraising events.

7. Reserves

The Trustees conduct an annual review of the level of financial reserves held by the company by considering the risks associated with the various income streams, expenditure plans and balance sheet items. This enables an estimate of the level of reserves that are required to be made and allow the Charity to meet its objectives.

The level set for the current year is £30,000 (2022 - £30,000). General funds amounted to £26,663 at the year end. Looking at future budgets and anticipated plans in the coming year, the Trustees believe the Charity is a going concern and has therefore adopted this method when preparing the accounts. Support for the Charity is anticipated to continue for the coming year.

8.

Financial Review

The Charity’s headline income of £105,717 (2022 - £127,605) was lower in what has been a very difficult year. Private donations were significantly lower at £23,655 (2022 - £41,032) as a result of the previously mentioned economic conditions, but corporate donations at £47,834 (2022 - £53,131) were also lower. This area in particular is one in which we will be investing more resources.

Total expenditure was £121,427 (2022 - £137,704) of which £56,583 (2022 - £70,619) was in support of the fundraising activities. The expenditure on charitable activities was £64,844 (2022 - £67,085), this continued low level of expenditure is a reflection of the reduced level of activity during the year. “Project Chrysalis” grants of £3,520 were made during the year (2022 - £0)

There was a net outflow of funds during the year of £15,710 (2022 - outflow £10,099), with reserves carried forward at the year-end totaling £26,663 (2022: £42,373). Once the reserves have increased to a satisfactory level, further funds will be made available for grant making in support of the Charity’s objectives. However, the trustees have also decided to take measures to improve the charity’s financial resilience by the looking to increase the level of restricted reserves

Page 6

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

9. Future Plans

The trustees are moving forwards with “Project Chrysalis” our innovative new approach to providing a focused and cost-effective mental health provision to families with a child suffering from Duchenne. This targeted approach will allow us to approach a wider range of potential grant providers to support this initiative. Grant-aided research projects will be a secondary consideration until surplus funds allow.

Duchenne is very much a “Cinderella” disease that remains unknown to the population at large. In 20 we will be continuing to extend our advocacy reach to increase the information and knowledge of this disease to policy makers and to the general population.

10. Economic Environment

There can be no doubt that the charitable sector is suffering from the impact of the recent high inflationary state of the UK economy. Domestic discretionary spending is both under threat and subject to increasing demands. We are adapting to this environment by reducing the number of events that we are sponsoring or taking places in (and thus reducing our expenditure exposure) and refocusing more towards applying to grant-giving organisations for future funding.

11. Statement of trustees’ responsibilities

The trustees (who are also directors of Harrison’s Fund for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

Page 7

REPORT OF THE TRUSTEES (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

12. Independent Examiners

Saffery LLP have expressed their willingness to continue in office. A resolution to re-appoint Saffery LLP as independent examiners will be proposed at the Annual General Meeting.

The Trustees have taken advantage of the small companies’ regime in preparing the Report to the Trustees.

16/09/2024

Approved by the Board of Trustees on ………………… and signed on its behalf by:

………………………… ……………………..

A D J Smith

D L Smith

Chief Executive Director/Trustee

Page 8

INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

I report to the charity trustees on my examination of the accounts of the company for the year ended 31 December 2023, which are set out on pages 10 to 18.

Respective responsibilities of trustees and examiner

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Basis of independent examiner's report

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a ‘true and fair view’ and the report is limited to those matters set out in the statement below.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Casidhe Baleri ACA CTA For and on behalf of Saffery LLP Chartered Accountants Midland House 2 Poole Road Bournemouth BH2 5QY Date: 18 September 2024

Page 9

STATEMENT OF FINANCIAL ACTIVITIES (Including Income and Expenditure account) FOR THE YEAR ENDED 31 DECEMBER 2023

2023 2022
Unrestricted Restricted Total Total
Notes Funds Funds Funds Funds
£ £ £ £
Income from
Donations and legacies 1 71,489 - 71,489 94,163
Events 34,228 - 34,228 33,442
Total income 105,717 - 105,717 127,605
Expenditure on
Costs of raising funds 3 56,583 - 56,583 70,619
Charitable activities 3 64,844 - 64,844 67,085
Total expenditure 121,427 - 121,427 137,704
Net gains on investments - - - -
Net movements in funds 10 (15,710) - (15,710) (10,099)
Fund balances at 1 January 2023 42,373 - 42,373 52,472
Fund balances at 31 December 2023 26,663 - 26,663 42,373

The notes on pages 12 to 18 form part of these accounts.

All the charity’s activities are classed as continuing.

All recognised gains and losses are included above.

Page 10

BALANCE SHEET AT 31 DECEMBER 2023

Notes

£
Fixed assets
Tangible fixed assets
6
Investments
7
Current assets
Stock
2,500
Cash at bank
22,821
Debtors
8
6,250
31,571
Creditors:Amounts falling due in less
than one year
9
(5,126)
Net current assets
Net assets
Represented by:
Unrestricted funds
10
26,663		 Notes

£
Fixed assets
Tangible fixed assets
6
Investments
7
Current assets
Stock
2,500
Cash at bank
22,821
Debtors
8
6,250
31,571
Creditors:Amounts falling due in less
than one year
9
(5,126)
Net current assets
Net assets
Represented by:
Unrestricted funds
10
26,663		 2023
£
97
121		 £
2,500
16,313
27,296		 2022
£
202
121
218
26,445		 323
42,050
31,571
(5,126)		 46,109
(4,059)
26,663 42,373
26,663 42,373
26,663 42,373
26,663 42,373

For the year ended 31 December 2023, the company was entitled to the exemption from the requirement to have an audit under section 477 of the Companies Act 2006. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibility for:

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime.

16/09/2024

The financial statements were approved by the board of directors on ……………… and signed on their behalf by:

A D J Smith D L Smith Chief Executive Director/Trustee Company Registered number: 07782637 (England and Wales) The notes on pages 12 to 18 form part of these accounts.

Page 11

ACCOUNTING POLICIES

A. Charity Information Harrison’s Fund Limited is a Charity domiciled and incorporated in England and Wales. The Registered Office is Midland House, 2 Poole Road, Bournemouth BH2 5QY.

B. Basis of accounting

The financial statements have been prepared under the historic cost convention, with the exception of listed investments which are included at their market value. The accounts (financial statements) have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) effective 1 January 2019 and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011and UK Generally Accepted Practice as it applies. Harrison’s Fund constitutes a public benefit entity as defined by FRS 102.

The following accounting policies have been applied consistently in dealing with items, which are considered material to the financial statements.

At the time of approving the financial statements, the trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

The charity has taken the exemption provided in Update Bulletin 1 updating Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) allowing small Charities not to prepare a cash flow statement.

Income is recognised at the date of receipt.

Costs of generating funds comprise the costs associated with attracting voluntary income and the fundraising activities of the charity.

Governance costs include those costs associated with meeting the constitutional and strategic requirements of the charity and include the audit fees and costs linked to the management of the charity.

Page 12

ACCOUNTING POLICIES (cont.)

G. Unrestricted funds

General reserves

The use of this fund has not been restricted to a particular purpose by the donor or their representatives.

Designated reserves

These are the reserves that have been designated to allow the charity to meet its objectives.

H. Restricted funds

These are the funds given for specific purposes and are detailed in note 9 if applicable

I. Tangible fixed assets

Fixed assets are stated at historical cost less depreciation. Depreciation is provided on all equipment at a rate calculated to write off the cost or valuation, less estimated residual value, of each asset evenly over its expected useful life. The rate used is 33.33% per annum straight line.

J. Investments

Unlisted equity investments are measured initially at cost and subsequently measured at fair value unless fair value cannot be measured reliably in which case they are measured at cost less impairment.

K. Stock

Stock is held at the lower of cost and net realisable value.

L. Financial instruments

The charity has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are recognised initially in the accounts at transaction price, including any transaction costs. At the end of each accounting period, basic financial instruments are recognised at amortised cost. For debt instruments this is calculated using the effective interest rate method.

M. Critical estimate and judgements and key sources of estimation uncertainty

In the application of the Charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision effects both current and future periods.

Page 13

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

1
Income
Voluntary income
Private donations
Corporate donations
2
Net income for the year
Net income is stated after charging:
Accountancy
Depreciation
3
Expenditure
Costs of generating funds for events
Volunteer event costs
Clothing costs
Support costs allocated on a time spent basis (note 5)
Charitable Activities
Grants paid
Support costs allocated on a time spent basis (note 5)
Total resources expended		 2023
£
23,655
47,834
71,489
2023
£
3,952
105
2023
£
1,881
353
54,349
56,583
3,520
61,324
64,844
121,427		 2022
£
41,032
53,131
94,163
2022
£
2,500
8,348
2022
£
7,107
-
63,512
70,619
-
67,085
67,085
137,704

Page 14

NOTES TO THE FINANCIAL STATEMENTS (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

4 Staff Costs

Staff Costs
Salaries and National Insurance 2023
£
97,896
97,896		 2022
£
104,432
104,432

No employees were paid more than £60,000 during the year. During the year the charity had 3 employees, (2022: 4) of whom 2 work for 3 days a week or less.

5 Support costs

Rent & Insurance
Printing & stationery
Telephone & IT costs
Depreciation
Travelling
Staff costs
Other costs
Accountancy		 Cost of
generating
Charitable
funds
Activities
248
165
410
274
4,929
3,286
63
42
2,571
1,713
46,066
51,830
62
62
-
3,952


54,349
61,324

 Total
2022
413
380
684 984
8,215
9,427
105
8,348
4,284
4,526
97,896
104,432
124
-
3,952
2,500
115,673
130,597

The support costs are allocated using a basis consistent with the time spent on activities.

Page 15

NOTES TO THE FINANCIAL STATEMENTS (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

6 Tangible fixed assets

angible fixed assets
Office
equipment
£
Cost
1 January 2023 53,338
Additions -
Disposals -
31 December 2023 53,338
Depreciation
1 January 2023 53,136
Charge for the year 105
Disposals -
31 December 2023 53,241
Net book value
31 December 2023 97
31 December 2022 202
7
Investments
Costs
1 January 2023
Additions
Disposals
31 December 2023		 121
-
-
121

The charity holds unlisted shares in Sutura Theraputics Ltd at a cost of £121. It has not been possible to reliably estimate the fair value of theses shares at the balance sheet date therefore they have been included at cost less impairment.

8
Debtors
Prepayments		 2023
£
6,250
6,250		 2022
£
27,296
27,296

Page 16

NOTES TO THE FINANCIAL STATEMENTS (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

Accruals
Taxation and Social Security
Pension Creditor		 2023
£
2,500
2,227
399
5,126		 2022
£
4,059
-
-
4,059

10 Movement in Funds

Total Unrestricted Funds
Total Reserves
Prior year
Total Unrestricted Funds
Total Reserves		 As at 1
January
2023
Incoming
resources
Outgoing
resources
Gains/
transfers
At 31
December
2023
£
£
£
£
42,373
105,717
121,427
-
26,663
42,373
105,717
121,427
-
26,663
As at 1
January
2022
Incoming
resources
Outgoing
resources
Gains/
transfers
At 31
December
2022
£
£
£
£
52,472
127,605
137,704
-
42,373
52,472
127,605
137,704
-
42,373

All assets relate to general funds.

11 Taxation

As a charity, Harrison’s Fund Limited is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or s256 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. No tax charges have arisen in the Charity.

Page 17

NOTES TO THE FINANCIAL STATEMENTS (continued) FOR THE YEAR ENDED 31 DECEMBER 2023

12 Transactions with Trustees

In May 2013, one of the Trustees, A D J Smith, was appointed to a full-time paid position as CEO of the charity. Beyond this, no member of the Board of Trustees received any remuneration during the year. During the year, the CEO received remuneration of £55,000 (2022: £55,000). Salary advances of £3,630 (2022: £25,012) are included in debtors. Travel costs amounting to £3,748 (2022: £3,873) were reimbursed to one member of the Board of Trustees. No other Trustee or other person related to the charity had any personal interest in any contract or transaction entered into by the charity during the year.

13 Liability of members

The Charity is a company limited by guarantee. A member’s contribution to the assets of the Charity in the event of it being wound up while he or she is a member or within one year of ceasing to be a member is limited to an amount not exceeding £10.

Page 18